Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-22

Clinical Trial Update: Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated estradiol patch as an add-on to antipsychotics for schizophrenia and related disorders; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antipsychotics (unspecified) (antipsychotics)
  • estradiol patch (estradiol)

Snippet

Sponsor: Tangent Data | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED